This destroys any near-term leverage we had in negotiating with potential partners to fund an FDA trial.
Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-38
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.5¢ |
Change
-0.002(2.30%) |
Mkt cap ! $76.63M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 8.7¢ | 8.5¢ | $12.66K | 146.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 197135 | 8.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.7¢ | 329525 | 1 |
View Market Depth
| Last trade - 10.14am 02/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |